Clinical Trial Update: Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. [Phase 1]

View source ↗

Summary

A completed Phase I trial evaluating marimastat for disabling malformations in patients with vascular anomalies, focusing on safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Anomalies

Drugs mentioned

• Marimastat (marimastat)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Vascular Anomalies | Phase 1 | Status: COMPLETED